ES2151222T3 - Compuestos del acido hidroxamico como agonistas de receptor opiaceo kappa. - Google Patents

Compuestos del acido hidroxamico como agonistas de receptor opiaceo kappa.

Info

Publication number
ES2151222T3
ES2151222T3 ES97200003T ES97200003T ES2151222T3 ES 2151222 T3 ES2151222 T3 ES 2151222T3 ES 97200003 T ES97200003 T ES 97200003T ES 97200003 T ES97200003 T ES 97200003T ES 2151222 T3 ES2151222 T3 ES 2151222T3
Authority
ES
Spain
Prior art keywords
alkyl
phenyl
optionally substituted
4alkyl
cycloalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97200003T
Other languages
English (en)
Inventor
Fumitaka Ito
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Application granted granted Critical
Publication of ES2151222T3 publication Critical patent/ES2151222T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/20—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)

Abstract

SE DESCRIBE UN COMPUESTO REPRESENTADO POR LA FORMULA SIGUIENTE: Y UNA SAL FARMACEUTICAMENTE ACEPTABLE DEL MISMO, DONDE: R{SUP,1} Y R{SUP,2} SON, INDEPENDIENTEMENTE, HIDROGENO, ALQUILO C{SUB,1-4}, CICLOALQUILO C{SUB,3-7}, ALQUENILO C{SUB,2-4}, ALCOXI C{SUB,1-4}-ALQUILO C{SUB,1-4}, ALQUILTIO C{SUB,1-4}-ALQUILO C{SUB,1-4}, FENILO, FENIL-ALQUILO C{SUB,1-4}, ALQUILO C{SUB,1-4} HALOSUSTITUIDO, CICLOALQUILO C{SUB,3-7}-ALQUILO C{SUB,1-3} O HIDROXI-ALQUILO C{SUB,1-4}; O R{SUP,1} Y R{SUP,2} UNIDOS ENTRE SI, JUNTO CON EL ATOMO DE NITROGENO AL QUE ESTAN UNIDOS, FORMAN HETEROCICLOS DE 3-, 4-, 5-, 6- O 7- MIEMBROS, SATURADOS O INSATURADOS , QUE CONTIENEN UNO O DOS HETEROATOMOS, A CONDICION DE QUE DICHO HETEROCICLO NO SEA PIRROLIDINILO; R{SUP,3} ESHIDROGENO O ALQUILO C{SUB,1-4}, O UN GRUPO PROTECTOR DE HIDROXILO; AR ESFENILO OPCIONALMENTE O FENIL-ALQUILO C{SUB,1-3}; Y X ES FENILO OPCIONALMENTE SUSTITUIDO, NAFTILO, BIFENILO, INDANILO, BENZOFURANILO, BENZOTIOFENILO, 1-TETRALONA-6-ILO, ALQUILENODIOXI C{SUB,1-4}, PIRIDILO, FURILO O TIENILO. DICHOS COMPUESTOS Y LAS COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN, SON UTILES COMO AGENTES ANALGESICOS, ANTIINFLAMATORIOS, DIURETICOS, ANTITUSIVOS, ANESTESICOS, O NEUROPROTECTORES, O UN AGENTE PARA EL TRATAMIENTO DE ATAQUES O DE LA ENFERMEDAD FUNCIONAL DEL COLON, COMO EL DOLOR ABDOMINAL, PARA EL TRATAMIENTO DE UN MAMIFERO, ESPECIALMENTE DE UN SUJETO HUMANO.
ES97200003T 1996-02-07 1997-01-07 Compuestos del acido hidroxamico como agonistas de receptor opiaceo kappa. Expired - Lifetime ES2151222T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IB9600099 1996-02-07

Publications (1)

Publication Number Publication Date
ES2151222T3 true ES2151222T3 (es) 2000-12-16

Family

ID=11004404

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97200003T Expired - Lifetime ES2151222T3 (es) 1996-02-07 1997-01-07 Compuestos del acido hidroxamico como agonistas de receptor opiaceo kappa.

Country Status (10)

Country Link
US (1) US5837717A (es)
EP (1) EP0789021B1 (es)
JP (1) JP3190588B2 (es)
AT (1) ATE196901T1 (es)
CA (1) CA2196845C (es)
DE (1) DE69703256T2 (es)
DK (1) DK0789021T3 (es)
ES (1) ES2151222T3 (es)
GR (1) GR3034923T3 (es)
MX (1) MX9701042A (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL130429A0 (en) * 1998-08-24 2000-06-01 Pfizer Prod Inc Process for preparing pyrrolidinyl hydroxamic acid compounds
US7160902B2 (en) * 2003-11-14 2007-01-09 Adolor Corporation Amide derivatives and methods of their use

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8618188D0 (en) * 1986-07-25 1986-09-03 Ici Plc Diamine compounds
DE4034785A1 (de) 1990-11-02 1992-05-07 Merck Patent Gmbh 1-(2-arylethyl)-pyrrolidine
US5232978A (en) * 1988-12-23 1993-08-03 Merck Patent Gesellschaft Mit Beschrankter Haftung 1-(2-arylethyl)-pyrrolidines
JPH0730061B2 (ja) * 1991-02-07 1995-04-05 ファイザー製薬株式会社 ヒドロキサム酸誘導体および組成物
US5132319A (en) * 1991-03-28 1992-07-21 Merck Frosst Canada, Inc. 1-(hydroxylaminoalkyl) indole derivatives as inhibitors of leukotriene biosynthesis
US5128364A (en) * 1991-03-28 1992-07-07 Merck Frosst Canada, Inc. Pyrrolo[1,2-a]indole hydroxylamine derivatives as inhibitors of leukotriene biosynthesis
US5234933A (en) * 1991-10-31 1993-08-10 Board Of Governors Of Wayne State University And Vanderbilt University Cyclic hydroxamic acids
IL117440A0 (en) * 1995-03-31 1996-07-23 Pfizer Pyrrolidinyl hydroxamic acid compounds and their production process

Also Published As

Publication number Publication date
MX9701042A (es) 1998-05-31
DE69703256T2 (de) 2001-02-22
DK0789021T3 (da) 2000-11-13
EP0789021B1 (en) 2000-10-11
CA2196845C (en) 2001-08-21
US5837717A (en) 1998-11-17
CA2196845A1 (en) 1997-08-08
EP0789021A1 (en) 1997-08-13
JP3190588B2 (ja) 2001-07-23
JPH11180950A (ja) 1999-07-06
DE69703256D1 (de) 2000-11-16
GR3034923T3 (en) 2001-02-28
ATE196901T1 (de) 2000-10-15

Similar Documents

Publication Publication Date Title
KR102401841B1 (ko) 에스트로겐 수용체 조절제
NO20013808L (no) Anti-inflammatoriske indolderivater
ES2102132T3 (es) Amidas de acidos carboxilicos heterociclicos sustituidos, su preparacion y su utilizacion como medicamentos.
HUP0002272A2 (hu) Piperazinszármazékok, eljárás előállításukra, e vegyületeket tartalmazó gyógyászati készítmények és alkalmazásuk
HU907660D0 (en) Process for producing tricyclic compounds and pharmaceutical preparatives containing such compounds as active substances
WO2002032900A3 (en) Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents
EA200400226A1 (ru) Новые пирролы, обладающие гиполипидемической и гипохолестеринемической активностью, способ их получения и содержащие их фармацевтические композиции и их применение в медицине
SE9904508D0 (sv) New compounds
RU2004125145A (ru) Производные гетероциклических амидов, обладающие ингибиторной активностью в отношении гликогенфосфорилазы
EP0842923A4 (en) PYRROL DERIVATIVES AND MEDICAL PREPARATION.
RU94044454A (ru) Ингибитор аутоимунных заболеваний
TW243449B (es)
MY111702A (en) 5-amino-8-methyl-7-pyrrolidinylquinoline-3-carboxylic acid derivative
CA2213815A1 (en) Pyrrolidinyl hydroxamic acid compounds and their production process
CA2215659A1 (en) Morphinan hydroxamic acid compounds
PT94711B (pt) Processo para a preparacao de derivados de isoquinolina
ES2151222T3 (es) Compuestos del acido hidroxamico como agonistas de receptor opiaceo kappa.
KR880005927A (ko) 카복실산 아미드의 용도
EA200100597A2 (ru) Новые 1,1- и 1,2-дизамещенные циклопропановые соединения, способ их получения и содержащие их фармацевтические композиции
ES2262504T3 (es) Derivados del acido piroglutamico y compuestos afines que inhiben la adhesion de leucocitos mediada por la vla-4.
AR009374A1 (es) Compuestos novedosos antagonistas de nmda (n-metil-d-aspartato), composicion farmaceutica y usos para fabricar medicamentos.
EP1591441A4 (en) CARBON ACID COMPOUNDS
AU3231901A (en) Phenoxyalkylamine derivatives useful as opioid delta receptor agonists
MXPA05003972A (es) Abridor de canal de k activado por calcio de alta conductancia.
KR970704723A (ko) 항염증제로서 유용한 디히드로벤조푸란 및 관련 화합물(dihydrobenzofuran and related compounds useful as anti-inflammatory agents)

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 789021

Country of ref document: ES